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Word count (including abstract 3313) 6 Abstract 7 Angiostrongylus is associated with bleeding tendencies in approximately 1/3 of 8 clinical cases, but the cause of the coagulopathy is poorly understood although 9 DIC is a proposed cause (Koch & Willesen 2009).  Thromboelastography (TEG) is 10 a global evaluation of coagulation and has not been described in a cohort of dogs 11 with this disease.  Thromboelastography in association with other measures of 12 coagulation, PT, aPTT, antithrombin percentage activity, d-dimer concentration 13 and von Willebrand factor concentration were evaluated in a group of 30 dogs 14 with A.varosum infection. 18 dogs had signs of bleeding on physical examination. 15 TEG was consistent with hypocoagulation in 17 of these dogs. There was no 16 association between any of the other measures and hypocoagulation on TEG. 17 Abnormal coagulation times were not significantly associated with the presence 18 of bleeding.  Only fibrinogen concentration was significantly different, (lower) in 19 dogs that were bleeding compared to those that weren’t. D-dimer concentrations 20 were increased in 22/25 cases in the study, however other coagulation 21 parameters were more variable.  Although the changes identified in this study 22 were not consistent within groups there is activation of coagulation within this 23 population, possibly consistent with an intravascular disseminated 24 coagulopathy. 25 Introduction 26 Naturally occurring Angiostrongylus vasorum infection is associated with a 27 number of clinical syndromes in dogs. Bleeding tendencies were recognized in 28 approximately 1/3 of cases diagnosed in England in a small case series 29 (Chapman et al 2004).While the coagulopathy associated with A.vasorum has 30 been clinically recognized for some time the published information is limited to 31 case reports and experimental work (Schelling et al 1986, Ramsey et al 1996, 32 Gould & McInnes 1999, Cury et al 2002 and Whitley et al 2005).  A recent paper 33 suggests that the parasite in South America may be genetically distinct from the 34 parasite associated with natural infection in Europe throwing the clinical 35 
relevance of some of this experimental work to European patients into question 36 (Jefferies et al 2009). 37 There are a number of theories postulated that could explain the pathogenesis of 38 the bleeding diatheses seen in these patients, of which the presence of chronic 39 disseminated intravascular coagulation (DIC) seems to be most widely accepted 40 (Koch & Willesen 2009).   Other theories include acquired deficits in von 41 Willebrands factor, accumulation of immune complexes stimulating the intrinsic 42 coagulation system, immune mediated thrombocytopenia or inhibition of 43 coagulation due to factors secreted by the parasite (Caruso & Prestwood 1988, 44 Ramsey et al 1996, Gould & McInnes 1999, and Whitley et al 2005, O’Neill et al 45 2010). These studies have all used traditional methods of laboratory assessment 46 of haemostasis. Thromboelastography is a newer technique that provides a 47 global assessment of coagulation. It assesses both the influence of primary and 48 secondary coagulation on blood clotting, and can also be used to identify 49 hypercoagulability and clot strength. Thromboelastography in dogs with DIC has 50 been previously performed, with the most common finding being evidence of 51 hypercoagulability (Wiinberg B et al 2008). In this study 5 dogs had A. vasorum 52 infection, 4 of which were hypercoagulable with the fifth normal on 53 thromboelastography.  It was not reported whether these dogs had signs of 54 bleeding or not. 55 This study describes the haemostatic abnormalities seen in dogs diagnosed with 56 naturally occurring A.vasorum in an endemic area of England through evaluation 57 of traditional and global coagulation tests including thromboelastography.  58 Further evaluation for the presence of thrombosis and fibrinolysis was also 59 performed looking for markers of DIC such as increased D-dimers and low 60 fibrinogen concentrations.  As thromboelastography (TEG) is thought to be a 61 more global assessment for bleeding tendancies than PT and PTT we theorized 62 that all dogs with signs of haemorrhage would have abnormalities on TEG. We 63 also theorized that dogs presenting with clinical signs of haemorrhage would 64 have more marked abnormalities in their coagulation parameters than those that 65 were not confirmed to be bleeding. 66 
Materials and methods 67 Dogs presenting at a referral hospital with a diagnosis of Angiostrongylus 68 
vasorum were enrolled into the study. Dogs were referred to the hospital for 69 investigation and management of a variety of clinical signs and were diagnosed 70 with the condition during investigation.  Diagnosis of A.vasorum was based upon 71 identification of L3 larvae in the faeces of affected dogs using Baermann 72 sediment evaluation. Faecal samples were collected by collection after voiding or 73 rectal examination. In most cases a single faecal sample was used for Baermann 74 examination due to the requirement for a rapid diagnosis.  As the result of this 75 diagnosis is often delayed by 24 hours and dogs were enrolled if suspicion of the 76 disease was high and later excluded if Baermann was negative. Dogs were also 77 excluded if treated with agents effective against A.vasorum prior to testing. 78 Owner consent was obtained for enrollment in the study. Institutional ethical 79 approval was obtained prior to the start of the study. 80 Clinical information collected for each case included signalment, main presenting 81 signs, whether there were bleeding diatheses on physical examination, post-82 mortem examination or magnetic resonance imaging and outcome.   83 Blood was collected atraumatically by venipuncture using a syringe and needle 84 of the jugular or saphenous vein and submitted for analysis on the day of 85 admission.   86 Thromboelastography was performed between 30 minutes and 2 hours after 87 sampling according to in-house standard operating procedures.  The samples 88 were not activated prior to analysis. Citrated whole blood samples were used 89 and added to a cup containing 280mmol CaCl2 to give a total volume of 90 360ul/cup.  A heparinase cup was used in all samples in case of prior heparin 91 exposure.  The analyses were run for a total of 120 minutes and readings were 92 obtained continuously by the machine during this time. Measurements obtained 93 from the analysis included reaction time (R), Clotting time (K), Angle (alpha), 94 Maximum amplitude (MA) and global clot strength (G).  Results were compared 95 with a previously established reference range for this machine, using this 96 technique (Goodwin et al 2011). 97 
Excess citrated plasma was obtained by centrifugation at 4000x g for 2 minutes; 98 it was then separated and frozen at -30°C until analysis via batch submission to 99 Cornell diagnostic laboratories. Samples were sent frozen on ice within 3 months 100 of sampling. The coagulation profile included prothrombin time (PT), activated 101 partial thromboplastin time (aPTT), antithrombin percentage activity (AT) by 102 chromogenic substrate method, fibrinogen concentration using the Clauss 103 method, von Willebrand’s factor antigen concentration by ELISA and d-dimer 104 concentration by quantitative immunoturbidometric assay. The reference 105 intervals were provided by the laboratory performing the analysis. Automated 106 platelet counts were performed on EDTA blood and a minimum platelet count 107 estimate was performed on blood smear examination by a clinical pathologist.  If 108 platelet counts could not be estimated due to clumping the clinical pathologist 109 made a rough assessment based upon a count in the body of the smear and this 110 was defined as adequate if greater than 150x109/l. 111 Dogs were defined as having increases of PT and aPTT if they were greater than 112 125% of the top end of the reference interval.  Dogs were defined as being 113 hypocoagulable if they had 2 or more of 4 of the following; increased R, 114 increased k, decreased alpha or decreased MA and hypercoagulable if 2 or more 115 of the following were present; decreased R, decreased k, increased alpha or 116 increased MA.  Decreased G was used as a global measure of hypocoagulability 117 and increased G as a global measure of hypercoagulability. 118 Statistical analysis 119 Data were entered into a statistical package for analysisA.  Data were analysed 120 for normality graphically and using the Kolmogorov-Smirnov test and are 121 presented as mean (+/- s.d.) when normally distributed and median (range) 122 when not.  For analysis the data were categorized into dogs with clinical signs of 123 bleeding and those that did not. Mann-Whitney U test was used for comparison 124 of groups in non-parametric data and an independent samples T-test was used 125 for parametric data.  A Fishers exact data was used for categorical data.  A p 126 value of less than 0.05 was considered significant. 127 
Results 128 
A total of 30 dogs were enrolled into the study.  All dogs had a confirmed 129 diagnosis of A.vasorum using the Baermann method after initial enrollment. 130 Complete data was available for 25 cases.  In 5 cases thromboelastography was 131 performed but traditional coagulation data was unavailable.  The majority of 132 dogs were purebred and represented eighteen different breeds with 133 Staffordshire bull terrier (6) and cocker spaniel (4) most commonly represented.   134 There were 8 female entire, 8 female neutered, 10 male entire and 4 male 135 neutered.  Median age was 2 years (range 0.3- 11). Presenting signs included 136 neurological abnormalities in 16 dogs, including seizures, ataxia, coma and 137 paralysis; spontaneous non-traumatic bleeding in 10, dyspnoea in 9 and 138 polydipsia and polyuria related to hypercalcaemia in 2. Some dogs presented 139 with more than one sign, most commonly neurological signs and bleeding into 140 the sclera.  141 Eighteen dogs presented with bleeding diatheses on physical examination, 142 imaging or at post-mortem examination. In a further 3 dogs bleeding was 143 suspected in the central nervous system, but not confirmed as no imaging or 144 investigation was performed; for statistical analysis these dogs are included in 145 the not bleeding group.   In 9 dogs no bleeding was identified or suspected.  146 Twenty-one dogs survived to discharge. Of the nine dogs that died 6 had 147 bleeding signs on presentation. 148 Platelet counts were available in 18 dogs.  Minimum estimates were made by a 149 clinical pathologist from a smear examination.  Clumps were present in 8 of 150 these blood smears making accurate estimation impossible.  In a further 3 dogs 151 the platelet count was stated to be adequate. Thrombocytopaenia (platelet count 152 <150 without clumps present) was confirmed in 4 dogs.  The median (range) 153 platelet count using the minimum estimated count was 133 x109/L (40-342).   154 Due to the subjective nature of this data no further analysis has been performed.  155 The coagulation panel was measured in 25 dogs.  Fifteen of these had signs of 156 bleeding.  Prothrombin time and aPTT were prolonged in 8/25,  aPTT was 157 abnormal in a further 4/25 cases.  Fibrinogen was decreased in 9/18 and 158 increased in 9/18 cases.  Antithrombin was within reference interval in 24/25 159 
cases (median 92.5% range 45-119 reference interval 65-145) and decreased in 160 1/25. D-dimer concentrations were increased in 22/25 cases, (median 611ng/ml 161 range 50-1511, reference interval 0-250). Von Willebrand’s factor antigen 162 concentration was decreased in 4/25 cases and increased in 8/25 cases.  At least 163 one coagulation measure was abnormal in 24/25 dogs and 3 or more were 164 abnormal in 14 dogs. 165 Nine out of ten dogs that did not have evidence of bleeding had normal 166 coagulation times (PT and aPTT).  Eight out of 15 dogs with bleeding diatheses 167 had normal coagulation times.  Abnormal coagulation times were not 168 significantly associated with the presence of bleeding diatheses. 169 There was no difference between antithrombin percentage activity, d-dimer 170 concentration and von Willebrand factor antigen concentrations in dogs that 171 were bleeding and those that were not bleeding. Fibrinogen concentration was 172 lower in those that were bleeding (median 108mg/dL, range 15-895), compared 173 with those that were not (median 545mg/dL, range 45-885) (p=0.026).  Table 1 174 summarises these findings.  Fibrinogen concentration was also lower in dogs 175 that had abnormal coagulation times (median 40,mg/dL range 15-50), compared 176 with those that did not (median 544mg/dL, range 108-895) (p=0.001).   177 TEG analysis was performed in 30 dogs.  Hypocoagulability was present in 22 178 out of 30 dogs.  Seventeen of the 18 dogs with bleeding signs were 179 hypocoagulable on TEG.  Five dogs with no evidence of bleeding were 180 hypocoagulable on TEG, two of these dogs had neurological signs; seizures and 181 hind limb paralysis, with the remainder presenting for dyspnoea.  182 Hypocoagulability identified on TEG was associated with the presence bleeding 183 diatheses (p=0.003).  Hypercoagulability was present in 3 out of 30 dogs. None of 184 these 3 dogs had signs of bleeding.  Two of these dogs were diagnosed with 185 pulmonary hypertension.  No other dogs were diagnosed with pulmonary 186 hypertension in this study, however echocardiography was not performed in all 187 cases. There were significant differences identified in R-time (R) (p=0.008), 188 angle (a) (p=0.001), maximum amplitude (MA) (p=0.004) and G (p=0.004) 189 between dogs that were bleeding and those that were not bleeding (Table 2).  K 190 
time could not be analysed as in 12 dogs the clot did not reach sufficient strength 191 to be able to allow measurement of a k time. There was no difference in 192 fibrinogen concentrations, d-Dimer concentration, antithrombin percentage 193 activity or von Willebrand factor concentration between dogs that were 194 hypocoagulable on TEG and those that were not (table 3). 195 Outcome was not different between dogs that had bleeding diatheses, had 196 abnormal PT or aPTT, or were hypocoagulable on TEG analysis.   197  198 Discussion 199 This is the first study to describe some of the changes in coagulation in a large 200 population of naturally infected dogs presenting with clinical signs of 201 angiostrongylosis including patients both with and without bleeding diatheses. It 202 is also the first study to report on TEG findings in this patient group.  It should be 203 noted that the population was a referral population and therefore likely 204 represents a more severely affected population than seen in first opinion 205 practice; the changes reported therefore may not represent the changes seen in 206 less severely affected dogs. The incidence of bleeding in first opinion cases is 207 likely to be lower, as seen in the study by Willesen et al (2009).  208 The signalment of dogs in this study is similar to that in other clinical studies 209 (Chapman et al 2004, Willesen et al 2009) although the incidence of bleeding 210 signs is higher in the group reported here. This is likely to be related to the 211 increased awareness of the disease over the last 10 years resulting in less 212 severely affected dogs being treated in first opinion practice. 213 Laboratory assessment of coagulation parameters in this study did not include 214 analysis of platelet count and function.  Platelet counts were only submitted in 215 21 dogs; this reflects that fact that many of these dogs would have been admitted 216 out of hours or at weekends and would therefore have had in house blood smear 217 evaluation performed.  In 18 dogs estimated platelet counts were available 218 although in 8 of these cases a minimum count was provided due to the presence 219 of clumps in the sample, resulting in a pseudothrombocytopenia. In a further 3 220 
samples no count was provided, only an estimation of adequate numbers.  It is 221 likely therefore that the median platelet count presented here is an 222 underestimation, however mild thrombocytopenia may also be a feature of this 223 disease as has been previously reported (Cury et al 2002).  Although it would 224 have been preferable to have more accurate platelet estimates in a higher 225 proportion of patients, it also seems unlikely that thrombocytopenia is the cause 226 of coagulopathy in this disease as most dogs had a platelet count above that at 227 which spontaneous haemorrhage is normally seen.  228 A large proportion of the study population had signs of bleeding identified on 229 physical examination or at post-mortem. It is possible that some dogs included in 230 the non-bleeding group had internal haemorrhage with no signs of external 231 haemorrhage which may have introduced bias.  This is particularly true of the 232 dogs presenting with neurological signs where bleeding has been identified as 233 the cause of signs in a number of cases (Garosi et al 2005, Wessmann et al 2006) 234 Inclusion in this way however allowed us to assess the dogs as set out in our 235 objectives. 236 Coagulation abnormalities were common in our population, with most dogs 237 having one or more abnormality present, however there was no typical pattern.  238 D-dimer concentrations were increased in 88% of dogs. Increased d-dimer 239 concentration is associated with increased fibrinolysis as can be seen in systemic 240 inflammation, neoplasia and following surgery.   It is also present in cases of 241 disseminated intravascular coagulation (Stokol et al 2000).  The changes in d-242 dimer concentrations seen in this study may be a result of systemic inflammation 243 or as a result of DIC. DIC is a complex coagulopathy associated with severe 244 underlying diseases.  It has features of both hypercoagulability and 245 hypocoagulability resulting in both thrombosis and bleeding.   DIC is a purported 246 mechanism for the coagulopathy of A.vasorum (Wiinberg et al 2008 and 2010) 247 and would explain the changes seen in fibrinogen concentration in this study.  248 Fibrinogen concentration was significantly lower, and outside of the reference 249 interval, in dogs that had signs of bleeding compared with those that did not.  250 The diagnosis of DIC has not been standardized in dogs, although there is a 251 model based scoring system (Wiinberg et al 2010).  Application of this scoring 252 
system was not possible in this study as it used specific ranges for tests run at 253 the authors’ laboratory. Our findings are suggestive of a consumptive process 254 with activation of coagulation, consistent with DIC.  It is not clear however 255 whether these changes are the cause of the haemorrhage or a result of it. 256  Increases in fibrinogen concentration were seen in 9 dogs; 257 hyperfibrinogenaemia has not been previously reported.  It is likely related to 258 the significant inflammatory response that occurs to the parasite in the 259 pulmonary parenchyma (Caruso & Prestwood 1988).    260 Routinely performed coagulation tests were abnormal in 40% of cases, most of 261 these dogs had signs of bleeding, however a further 8 dogs with signs of bleeding 262 had normal coagulation tests.  Hypocoagulability was identified on TEG in 22 263 dogs and 17 out of the 18 bleeding dogs had hypocoagulable TEGs.  As PT and 264 aPTT were normal in some cases it could be assumed that secondary coagulation 265 is intact in some dogs bleeding with A.vasorum and supports a role for 266 abnormalities in primary coagulation, including platelet function. Platelet 267 dysfunction is difficult to evaluate using TEG, as it represents a global evaluation 268 of coagulation.  Platelet dysfunction, however, tends to be associated with an 269 increased k and reduced MA on TEG, although this is not specific (Bowbrick et al 270 2003). Both of these were present in this population of dogs.  Platelet function 271 analysis was not performed in this group of dogs and given the findings and the 272 suggestion of dysfunction would provide a logical area for further investigation.   273 TEG did identify hypocoagulability in 2 dogs presenting with neurological 274 disease with no other visible signs of bleeding.  Although haemorrhage was not 275 confirmed in these dogs it seems a reasonable explanation.  Given these findings 276 TEG does not seem to offer any clear advantage over physical examination for 277 identification of haemorrhage, however, it may be beneficial in cases where 278 bleeding is the suspected pathogenesis and other tests have failed to identify a 279 cause. 280  281 Identification of hypercoagulability is a useful application of TEG and in this 282 series 3 dogs with hypercoagulability were identified. In 2 of these dogs 283 
pulmonary hypertension was present, which was attributed to hypoxia and 284 infiltration associated with angiostrongylosis.  Pulmonary hypertension was not 285 identified in any other dogs in this study, however echocardiography was not 286 performed and therefore the incidence of pulmonary hypertension in this 287 population is unknown. No other dogs showed clinical signs attributable to right 288 sided heart failure.  The relationship between hypercoagulability and pulmonary 289 hypertension associated with angiostrongylosis would be an interesting area for 290 further investigation as it may provide future therapeutic options. 291 This study provides some interesting results, but does not completely explain 292 what is happening in dogs with bleeding signs secondary to angiostrongylosis.  293 Dogs presenting with signs of haemorrhage have hypocoagulability present on 294 TEG, but inconsistently have alterations in secondary coagulation. D-dimer 295 concentrations are increased and may hint at the presence of DIC.  In particular 296 the findings suggest alterations in primary haemostasis.  Further analysis of 297 platelet function should be prioritized as an area of research in these dogsTEG 298 may be useful in association with PT and aPTT in dogs presenting with bleeding 299 in order to decide on the best use of blood products.  In the presence of clinically 300 relevant haemorrhage alterations in PT and aPTT would provide an indication 301 for the use of fresh frozen plasma, whereas if these were normal with 302 hypocoagulability on TEG primary haemostatic dysfunction may be suspected 303 and other therapies may be preferred.  While TEG provides the clinician with a 304 method of globally evaluating coagulation it does not specifically evaluate 305 platelet function and other methodologies may be more suitable for this such as 306 multiple electrode aggregometry or advanced whole clot analysis.  Because of its 307 high sensitivity for identification of coagulopathy in this population TEG also be 308 used to rule out significant coagulopathies.   Although in bleeding dogs it does 309 not seem to confer benefits in clinical practice over careful and thorough clinical 310 examination or clinical suspicion of haemorrhage use of TEG may be particularly 311 beneficial for identification of hypercoagulability and may influence therapy in 312 this group in particular. 313  314 
ASPSS Statistics 21, IBM, Hampshire, UK 315 References: 316 
• Bowbrick, V.A,, Mikhailidis D.P., & Stansby, G. (2009) Value of Thromboelastography in 317 
the Assessment of Platelet Function Clinical and Applied Thrombosis/Hemostasis 9: 137-318 
142 319 
Caruso, J.P., Prestwood, A.K (1988) Immunopathogenesis of canine angistrongylosis: 320 
Pulmonary effects of infection. Comparative Immunology, Microbiology and 321 
Infectious Diseases, 11: 85-92. 322 
 323 
Chapman, P. S., Boag, A. K., Guitian, J. and Boswood, A. (2004), Angiostrongylus 324 
vasorum infection in 23 dogs (1999–2002). Journal of Small Animal Practice, 45: 435–325 
440 326 
Cury, M. C., Lima, W. S., Guimaraes, M. P., & Carvalho, M. G. (2002). Hematological 327 
and coagulation profiles in dogs experimentally infected with Angiostrongylus 328 
vasorum (Baillet, 1866). Veterinary parasitology, 104: 139-149. 329 
Garosi, L. S., Platt, S. R., McConnell, J. F., Wray, J. D. and Smith, K. C. (2005), 330 
Intracranial haemorrhage associated with Angiostrongylus vasorum infection in 331 
three dogs. Journal of Small Animal Practice, 46: 93–99 332 
Goodwin, L.V., Goggs, R., Chan, D.L. and Allenspach, K. (2011), Hypercoagulability in 333 
Dogs with Protein-Losing Enteropathy. Journal of Veterinary Internal Medicine, 334 
25: 273–277.  335 
Gould, S. M. and McInnes, E. L. (1999), Immune-mediated thrombocytopenia 336 
associated with Angiostrongylus vasorum infection in a dog. Journal of Small Animal 337 
Practice, 40: 227–232 338 
Jefferies, R., Shaw, S. E., Viney, M. E., & Morgan, E. R. (2009). Angiostrongylus 339 
vasorum from South America and Europe represent distinct 340 
lineages. Parasitology, 136, 107-115. 341 
 342 
Koch, J., Willesen, J.L. (2009) Canine pulmonary angiostrongylosis: An update. The 343 
Veterinary Journal, 179:348-359 344 
 345 
O'Neill, E.J.,  Acke, E., Tobin, E., McCarthy, G. (2010) Immune-mediated 346 
thrombocytopenia associated with angiostrongylus vasorum infection in a Jack 347 
Russell terrier.  Irish Veterinary Journal, 63: 434–440 348 
 349 
Ramsey, I. K, Littlewood, J., Dunn, J. K. & Herrtage, M. E. (1996) Role of chronic 350 
disseminated intravascular coagulation in a case of canine 351 
angiostrongylosis. Veterinary Record 138, 360–363. 352 
Schelling CG, Greene CE, Prestwood AK, Tsang VC (1986) Coagulation abnormalities 353 
associated with acute Angiostrongylum vasorum infection in dogs. American Journal 354 
of Veterinary Research 47:2669–2673 355 
Stokol, T., Brooks, M.B., Erb, H.N., Mauldin, G.E. (2000) D-dimer concentrations in 356 
healthy dogs and dogs with disseminated intravascular coagulation. American 357 
Journal of Veterinary Research. 61:393-8. 358 
 359 
Whitley, N. T., Corzo-Menendez, N., Carmichael, N. G. and MCGarry, J. W. (2005), 360 
Cerebral and conjunctival haemorrhages associated with von Willebrand factor 361 
deficiency and canine angiostrongylosis. Journal of Small Animal Practice, 46: 75–78. 362 
Wiinberg, B., Jensen, A.L., Johansson, P.I., Rozanski, E., Tranholm, M. and Kristensen, 363 
A.T. (2008), Thromboelastographic Evaluation of Hemostatic Function in Dogs with 364 
Disseminated Intravascular Coagulation. Journal of Veterinary Internal Medicine, 365 
22: 357–365 366 
 367 
Wiinberg, B., Jensen, A.L., Johansson, P.I.,  Kjelgaard-Hansen, M., Rozanski, E., 368 
Tranholm, M., Kristensen, A.T. (2010) Development of a model based scoring system 369 
for diagnosis of canine disseminated intravascular coagulation with independent 370 
assessment of sensitivity and specificity. The Veterinary Journal 185: 292-298 371 
 372 
Willesen, J.L, Jensen, A.L.,  Kristensen, A.T., Koch, J. (2009) Haematological and 373 
biochemical changes in dogs naturally infected with Angiostrongylus vasorum before 374 
and after treatment. The Veterinary Journal, 180: 106-111. 375 
 376  377 Table One 378 Fibrinogen concentration, antithrombin percentage activity, d-dimer 379 concentration and von Willebrand factor concentration in dogs that had bleeding 380 diatheses and those that didn’t 381 Coagulation parameter Not bleeding n=10 Median (IQ range) Bleeding n=15 Median (IQ range) P value Fibrinogen (mg/dL) 545 (402) 108 (443) 0.026 Antithrombin (%) 87.5 (24) 90 (25) 0.935 d-dimer  (ng/ml) 606.5 (533) 701 (661) 0.461 Von Willebrand factor (%) 185 (103) 110 (93) 0.129  382 Table two 383 TEG parameters in animals that were bleeding compared with those without 384 evidence of bleeding 385 TEG parameter Not bleeding n-12 median (IQ Range) Bleeding  (s) n=18(median) p value R (minutes) 10.4 (5.9) 17.5(9.7) 0.008 K (minutes) 3.3 (3.0) N/A N/A A (angle) 40.0 (61.2) 10.0 (21.0) 0.001 
MA (mm) 55.5 (13.1) 18.6 (30.0) 0.004 G dynes/s 6.2(3.1) 1.2 (2.8) 0.004  386 Table three 387 Fibrinogen, antithrombin, D-dimers and von Willebrand factor concentrations in 388 dogs that were hypocoagulable on TEG and those that weren’t 389 Parameter Hypocoagulable n=18 Median (IQR) Not hypocoagulable n-7 Median (IQR) p value Fibrinogen (mmol/l) 4·09 (1·20–17·43) 15·99 (13·11–22·76) 0.097 Antithrombin (%) 89·0 (75·25–102·00) 90·0 (80·00–98·00) 0.745 D-dimers (nmol/l) 3·74 (1·86–5·35)  2·86 (1·63–4·44) 0.574 Von Willebrand factor (%) 117.5 (145) 176.0 (69) 0.357 
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